Risk factors and predictive model for hepatitis B virus deoxyribonucleic acid elevation in mid-to-late pregnancy with low viremia

doi:10.4254/wjh.124577

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

(2)

(0)

(13)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Hepatol. Oct 27, 2026; 18(10): 124577
Published online Oct 27, 2026. doi: 10.4254/wjh.124577

Table 5 Hepatitis B virus DNA elevated to high-risk pregnant women and neonatal follow-up outcomes

Case number	Prevention of MTCT during pregnancy	Timing of MTCT	Standard hepatitis B vaccination	Breastfeeding duration	HBsAg
1	No	-	Finish	1 month	Negative
2	No	-	Finish	12 months	Negative
3	No	-	Finish	1 month	Negative
4	Yes	32 weeks of gestation	Finish	8 months	Negative
5	No	-	Finish	3 months	Negative
6	No	-	Finish	4 months	Negative
7	No	-	Finish	0 months	Negative
8	Yes	28 weeks of gestation	Finish	5 months	Negative
9	Yes	26 weeks of gestation	Finish	8 months	Negative
10	Yes	31 weeks of gestation	Finish	8 months	Negative
11	-	-	-	-	-
12	No	-	Finish	2 months	Negative
13	Yes	31 weeks of gestation	Finish	24 months	Negative
14	No	-	Finish	7 months	Negative
15	No	-	Finish	9 months	Negative
16	No	-	Finish	8 months	Negative
17	No	-	Finish	1 month	Negative
18	No	-	Finish	5 days	Negative
19	No	-	Finish	6 months	Negative

MTCT: Mother-to-child transmission; HBsAg: Hepatitis B surface antigen.

Full Size Table

Citation: Chen Z, Chen H, Jie B, Peng T, Lin Y, Geng Y, Shen Y, Deng Y, Xie D, Yang L, Ouyang S. Risk factors and predictive model for hepatitis B virus deoxyribonucleic acid elevation in mid-to-late pregnancy with low viremia. World J Hepatol 2026; 18(10): 124577
URL: https://www.wjgnet.com/1948-5182/full/v18/i10/124577.htm
DOI: https://dx.doi.org/10.4254/wjh.124577

Chen Z, Chen H, Jie B, Peng T, Lin Y, Geng Y, Shen Y, Deng Y, Xie D, Yang L, Ouyang S. Risk factors and predictive model for hepatitis B virus deoxyribonucleic acid elevation in mid-to-late pregnancy with low viremia. World J Hepatol 2026; 18(10): 124577 [DOI: 10.4254/wjh.124577]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.